Lv1
20 积分 2025-09-19 加入
Sequential Systemic Treatment in Advanced Hepatocellular Carcinoma Is Able to Prolong Median Survival to More than 3 Years in a Selected Real-World Cohort
31分钟前
待确认
Robust group sequential designs for trials with survival endpoints and delayed response
1小时前
已完结
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
7天前
已完结
皖公网安备34019202002308
